ArticleCancers2026

Plasma 4β-Hydroxycholesterol Predicts Ribociclib CYP3A-Mediated Metabolism, but Not Plasma Exposure, in Patients with Primary Brain Cancer.

Charuka Wickramasinghe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.